My foundational work in molecular imaging and radiological sciences provided invaluable insights into the design and application of imaging agents. However, recognizing the broader potential and critical need in the field of medicine, I strategically pivoted my research focus toward drug development and preclinical studies. This transition was not merely a change in direction but a commitment to address pressing healthcare challenges. Leveraging the expertise from my early work in imaging, I am now dedicated to spearheading innovative drug development initiatives, emphasizing rigorous preclinical evaluations to ensure the safety and efficacy of novel therapeutic agents.